A decade of medical innovation for neglected patients
In just 10 years the Drugs for Neglected Diseases initiative (DNDi) has delivered six new treatments for four neglected diseases. On DNDi's anniversary, MSF reflects on its role in founding the initiative, DNDi's successes, and what challenges await DNDi in the future. » READ MORE
2013 © MSF
COUNTRIES MUST FIX TPP FLAWS
Countries must prioritise fixing critical flaws in the Trans-Pacific Partnership that could leave millions in developing countries with limited access to generic medicines.
India 2012 © Guddu
NOVARTIS' APPEAL REJECTED
The Supreme Court's decision to uphold India's Patents Act in the face of Novartis' challenge is a victory for access to medicines in developing countries.
2013 © MSF
GAVI: OPEN YOUR PRICES TO US
Help MSF reach more children with life-saving vaccines. Join us in calling on GAVI and pharmaceutical companies to extend their discounts to NGOs.
What is the Campaign?
Médecins Sans Frontières set up the Access Campaign in 1999 to push for access to, and the development of life-saving and life prolonging medicines, diagnostic tests and vaccines for patients in MSF programmes and beyond.
